Organization Statistics
Avg Compliance Rate
48.60%
Compliant Trials
486
Incompliant submissions
514
Total Organizations
46697
Total trials
1000
Filter Organizations
Compare Organization Compliance Rates
Showing 46025 of 46697 entries
View as:
0.0% Compliant
Total: 4
Funding: N/A
Compliant:
0
Late:
0
Wilson LCB:
N/A
Reporting Rate: N/A
Compliance Rate: 0.0%
0.0% Compliant
Total: 7
Funding: N/A
Compliant:
0
Late:
0
Wilson LCB:
N/A
Reporting Rate: N/A
Compliance Rate: 0.0%
0.0% Compliant
Total: 1
Funding: N/A
Compliant:
0
Late:
0
Wilson LCB:
N/A
Reporting Rate: N/A
Compliance Rate: 0.0%
0.0% Compliant
Total: 6
Funding: N/A
Compliant:
0
Late:
0
Wilson LCB:
N/A
Reporting Rate: N/A
Compliance Rate: 0.0%
0.0% Compliant
Total: 3
Funding: N/A
Compliant:
0
Late:
0
Wilson LCB:
N/A
Reporting Rate: N/A
Compliance Rate: 0.0%
0.0% Compliant
Total: 19
Funding: N/A
Compliant:
0
Late:
0
Wilson LCB:
N/A
Reporting Rate: N/A
Compliance Rate: 0.0%
0.0% Compliant
Total: 1
Funding: N/A
Compliant:
0
Late:
0
Wilson LCB:
N/A
Reporting Rate: N/A
Compliance Rate: 0.0%
0.0% Compliant
Total: 6
Funding: N/A
Compliant:
0
Late:
0
Wilson LCB:
N/A
Reporting Rate: N/A
Compliance Rate: 0.0%
0.0% Compliant
Total: 34
Funding: N/A
Compliant:
0
Late:
0
Wilson LCB:
N/A
Reporting Rate: N/A
Compliance Rate: 0.0%
0.0% Compliant
Total: 1
Funding: N/A
Compliant:
0
Late:
0
Wilson LCB:
N/A
Reporting Rate: N/A
Compliance Rate: 0.0%
0.0% Compliant
Total: 4
Funding: N/A
Compliant:
0
Late:
0
Wilson LCB:
N/A
Reporting Rate: N/A
Compliance Rate: 0.0%
0.0% Compliant
Total: 8
Funding: N/A
Compliant:
0
Late:
0
Wilson LCB:
N/A
Reporting Rate: N/A
Compliance Rate: 0.0%
0.0% Compliant
Total: 2
Funding: N/A
Compliant:
0
Late:
0
Wilson LCB:
N/A
Reporting Rate: N/A
Compliance Rate: 0.0%
0.0% Compliant
Total: 1
Funding: N/A
Compliant:
0
Late:
0
Wilson LCB:
N/A
Reporting Rate: N/A
Compliance Rate: 0.0%
0.0% Compliant
Total: 1
Funding: N/A
Compliant:
0
Late:
0
Wilson LCB:
N/A
Reporting Rate: N/A
Compliance Rate: 0.0%
0.0% Compliant
Total: 76
Funding: N/A
Compliant:
0
Late:
0
Wilson LCB:
N/A
Reporting Rate: N/A
Compliance Rate: 0.0%
0.0% Compliant
Total: 2
Funding: N/A
Compliant:
0
Late:
0
Wilson LCB:
N/A
Reporting Rate: N/A
Compliance Rate: 0.0%
0.0% Compliant
Total: 9
Funding: N/A
Compliant:
0
Late:
0
Wilson LCB:
N/A
Reporting Rate: N/A
Compliance Rate: 0.0%
0.0% Compliant
Total: 1
Funding: N/A
Compliant:
0
Late:
0
Wilson LCB:
N/A
Reporting Rate: N/A
Compliance Rate: 0.0%
0.0% Compliant
Total: 1
Funding: N/A
Compliant:
0
Late:
0
Wilson LCB:
N/A
Reporting Rate: N/A
Compliance Rate: 0.0%
0.0% Compliant
Total: 1
Funding: N/A
Compliant:
0
Late:
0
Wilson LCB:
N/A
Reporting Rate: N/A
Compliance Rate: 0.0%
0.0% Compliant
Total: 1
Funding: N/A
Compliant:
0
Late:
0
Wilson LCB:
N/A
Reporting Rate: N/A
Compliance Rate: 0.0%
0.0% Compliant
Total: 1
Funding: N/A
Compliant:
0
Late:
0
Wilson LCB:
N/A
Reporting Rate: N/A
Compliance Rate: 0.0%
0.0% Compliant
Total: 1
Funding: N/A
Compliant:
0
Late:
0
Wilson LCB:
N/A
Reporting Rate: N/A
Compliance Rate: 0.0%
0.0% Compliant
Total: 1
Funding: N/A
Compliant:
0
Late:
0
Wilson LCB:
N/A
Reporting Rate: N/A
Compliance Rate: 0.0%
| Sponsor | Funding Source | Total Trials | Reporting Rate | Compliant Trials | Late Submissions | Compliance Rate | Wilson LCB Score | Email Domain | Created Date |
|---|---|---|---|---|---|---|---|---|---|
| Zodiac Produtos Farmaceuticos S.A. | - | 4 | 0.0% | 0 | 0 | 0.0% | - | Zodiac Produtos Farmaceuticos S.A..temp.org | 2025-07-14 |
| Zoe Global Limited | - | 7 | 0.0% | 0 | 0 | 0.0% | - | Zoe Global Limited.temp.org | 2025-07-14 |
| Zofia Piotrowska | - | 1 | 0.0% | 0 | 0 | 0.0% | - | Zofia Piotrowska.temp.org | 2025-07-14 |
| Zogenix International Limited, Inc., a subsidiary of Zogenix, Inc. | - | 6 | 0.0% | 0 | 0 | 0.0% | - | Zogenix International Limited, Inc., a subsidiary of Zogenix, Inc..temp.org | 2025-07-14 |
| Zogenix MDS, Inc. | - | 3 | 0.0% | 0 | 0 | 0.0% | - | Zogenix MDS, Inc..temp.org | 2025-07-14 |
| Zogenix, Inc. | - | 19 | 0.0% | 0 | 0 | 0.0% | - | Zogenix, Inc..temp.org | 2025-07-14 |
| Zohaib Akram | - | 1 | 0.0% | 0 | 0 | 0.0% | - | Zohaib Akram.temp.org | 2025-07-14 |
| Zohra Institute of Health Sciences | - | 6 | 0.0% | 0 | 0 | 0.0% | - | Zohra Institute of Health Sciences.temp.org | 2025-07-14 |
| Zoll Medical Corporation | - | 34 | 0.0% | 0 | 0 | 0.0% | - | Zoll Medical Corporation.temp.org | 2025-07-14 |
| Zoltan Pataky | - | 1 | 0.0% | 0 | 0 | 0.0% | - | Zoltan Pataky.temp.org | 2025-07-14 |
| Zomagen Biosciences Ltd. | - | 4 | 0.0% | 0 | 0 | 0.0% | - | Zomagen Biosciences Ltd..temp.org | 2025-07-14 |
| ZonMw: The Netherlands Organisation for Health Research and Development | - | 8 | 0.0% | 0 | 0 | 0.0% | - | ZonMw: The Netherlands Organisation for Health Research and Development.temp.org | 2025-07-14 |
| Zona Health, Inc | - | 2 | 0.0% | 0 | 0 | 0.0% | - | Zona Health, Inc.temp.org | 2025-07-14 |
| Zongda Hospital affiliated to Southeast University | - | 1 | 0.0% | 0 | 0 | 0.0% | - | Zongda Hospital affiliated to Southeast University.temp.org | 2025-07-14 |
| Zonguldak Ataturk State Hospital | - | 1 | 0.0% | 0 | 0 | 0.0% | - | Zonguldak Ataturk State Hospital.temp.org | 2025-07-14 |
| Zonguldak Bulent Ecevit University | - | 76 | 0.0% | 0 | 0 | 0.0% | - | Zonguldak Bulent Ecevit University.temp.org | 2025-07-14 |
| Zongxun Lin | - | 2 | 0.0% | 0 | 0 | 0.0% | - | Zongxun Lin.temp.org | 2025-07-14 |
| Zosano Pharma Corporation | - | 9 | 0.0% | 0 | 0 | 0.0% | - | Zosano Pharma Corporation.temp.org | 2025-07-14 |
| Zou Junjie | - | 1 | 0.0% | 0 | 0 | 0.0% | - | Zou Junjie.temp.org | 2025-07-14 |
| Zouqin Huang | - | 1 | 0.0% | 0 | 0 | 0.0% | - | Zouqin Huang.temp.org | 2025-07-14 |
| Zoya Haitov Ben Zikri | - | 1 | 0.0% | 0 | 0 | 0.0% | - | Zoya Haitov Ben Zikri.temp.org | 2025-07-14 |
| Zoé van Kempen | - | 1 | 0.0% | 0 | 0 | 0.0% | - | Zoé van Kempen.temp.org | 2025-07-14 |
| Zsolt Molnár, MD, PhD, DEAA | - | 1 | 0.0% | 0 | 0 | 0.0% | - | Zsolt Molnár, MD, PhD, DEAA.temp.org | 2025-07-14 |
| Zu-xia Ma | - | 1 | 0.0% | 0 | 0 | 0.0% | - | Zu-xia Ma.temp.org | 2025-07-14 |
| Zubeyde Ezgi Ercelik | - | 1 | 0.0% | 0 | 0 | 0.0% | - | Zubeyde Ezgi Ercelik.temp.org | 2025-07-14 |